Rocket Lab Corp. (RKLB)

Q: What's priced into Rocket Lab Corp. (RKLB) stock?

The valuation model shows a premium versus peers, with some support from the potential value of future opportunities, or optionality. The expectations gap is negative, which suggests expectations may be ahead of what current fundamentals support; confidence in that estimate is low, and the evidence does not give a firm valuation conclusion.

Q: What does the Rocket Lab Corp. (RKLB) outlook hinge on?

Over the next few quarters, the thesis depends on avoiding a guidance cut and sustaining revenue and backlog growth. Over the multi-year view, key swing factors are closing the Iridium acquisition as expected, managing its funding, and delivering Neutron after the schedule adjustment. Industrial-sector results could also strengthen or weaken the sector backdrop.

NASDAQIndustrialsAerospace & DefenseSnapshot 2026-10-23

$52.60+2.69%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Rocket Lab Corp.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$250M–$265M	—
EBITDA	-$23M–-$17Mnon-GAAP	—
Gross margin	29%–31%GAAP 35%–37%non-GAAP	—
Operating expenses	$143M–$149MGAAP $121M–$127Mnon-GAAP	—
FY 2026 · Q4
Revenue	—	264.61M
EPS	—	-0.053
FY 2026 · Annual
Revenue	—	959.07M
EPS	—	-0.286
FY 2027 · Annual
Revenue	—	1.36B
EPS	—	-0.042

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
CEO maintains leadership commitment and supports growth	A supporting condition in Rocket Lab Corp.'s published investment case. The stated target is No significant CEO stake sales or leadership concerns.	Improving	CEO sells large stake or leadership doubts rise	No CEO stake sales reported News shows Neutron delays but no CEO selling or leadership concerns. CFO hire and M&A activity support stability. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Adjusted EBITDA loss limited to $20M-$26M in Q2 2026	Losses should shrink toward a $20M-$26M adjusted EBITDA loss in Q2.	Improving	Adjusted EBITDA loss exceeds $26 million in Q2 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Gross margin between 33% and 35% in Q2 2026	A primary condition in Rocket Lab Corp.'s published investment case. The stated target is 33% to 35%.	Intact	Gross margin falls below 33% in Q2 2026	Gross margin: 36.13% FY2026-Q2; GAAP. Published target: 33% to 35%. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 10, 202636.133398 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: cce09216-0030-4430-8876-9c40801a5795. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Management guided GAAP gross margins of 33%-35% for Q2 2026; actual gross margin was 36.1%, slightly above guidance. The company is delivering on its margin target with disciplined cost management. Delivery assessment Oct 24, 2026
Revenue between $225M and $240M in Q2 2026	A primary condition in Rocket Lab Corp.'s published investment case. The stated target is >= $225 million and <= $240 million.	Intact	Revenue falls below $225 million in Q2 2026	Revenue: $234.066M FY2026-Q2; GAAP. Published target: >= $225 million and <= $240 million. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 10, 2026234,066,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: cce09216-0030-4430-8876-9c40801a5795. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$-0.04

$-0.03 → $-0.04 · observed estimates

FY2027 revenue$1.36B

$1.28B → $1.36B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$-0.03	$1,281,164,390	11 / 17
2026-07-25	$-0.00	$1,278,909,916	9 / 14
2026-07-26	$-0.00	$1,278,909,916	9 / 14
2026-07-27	$-0.03	$1,281,164,390	11 / 17
2026-07-28	$-0.00	$1,278,909,916	9 / 14
2026-07-29	$-0.03	$1,270,674,670	11 / 16
2026-07-30	$-0.00	$1,314,692,699	9 / 14
2026-07-31	$-0.00	$1,314,692,699	9 / 13
2026-08-01	$-0.00	$1,314,692,699	9 / 13
2026-08-02	$-0.03	$1,270,674,670	11 / 16
2026-08-03	$-0.00	$1,314,692,699	9 / 13
2026-08-04	$-0.03	$1,270,674,670	11 / 16
2026-08-05	$-0.04	$1,286,382,040	12 / 17
2026-08-06	$-0.00	$1,314,692,699	9 / 13
2026-08-08	$-0.00	$1,314,692,699	9 / 13
2026-08-09	$-0.04	$1,286,382,040	12 / 17
2026-08-10	$-0.00	$1,314,692,699	9 / 13
2026-08-12	$-0.06	$1,342,130,790	11 / 16
2026-08-13	$-0.06	$1,342,130,790	11 / 16
2026-08-14	$-0.00	$1,314,692,699	9 / 13
2026-08-15	$-0.00	$1,314,692,699	9 / 13
2026-08-16	$-0.00	$1,314,692,699	9 / 13
2026-08-17	$-0.00	$1,314,692,699	9 / 13
2026-08-18	$-0.00	$1,314,692,699	9 / 13
2026-08-19	$-0.00	$1,314,692,699	9 / 13
2026-08-20	$-0.04	$1,394,280,534	9 / 13
2026-08-21	$-0.04	$1,394,280,569	9 / 14
2026-08-22	$-0.04	$1,394,280,569	9 / 14
2026-08-23	$-0.04	$1,394,280,569	9 / 14
2026-08-24	$-0.04	$1,394,280,569	9 / 14
2026-08-25	$-0.04	$1,394,280,569	9 / 14
2026-08-26	$-0.04	$1,394,280,569	9 / 14
2026-08-27	$-0.04	$1,394,280,569	9 / 14
2026-08-28	$-0.04	$1,394,280,569	9 / 14
2026-08-29	$-0.04	$1,394,280,569	9 / 14
2026-08-30	$-0.04	$1,394,280,569	9 / 14
2026-08-31	$-0.04	$1,400,533,075	9 / 14
2026-09-01	$-0.04	$1,400,533,075	9 / 14
2026-09-02	$-0.04	$1,400,533,075	9 / 14
2026-09-03	$-0.04	$1,396,614,570	9 / 14
2026-09-04	$-0.04	$1,396,614,570	9 / 14
2026-09-05	$-0.04	$1,396,614,570	9 / 14
2026-09-06	$-0.04	$1,396,614,570	9 / 14
2026-09-07	$-0.04	$1,396,614,570	9 / 14
2026-09-08	$-0.04	$1,396,614,570	9 / 14
2026-09-09	$-0.04	$1,396,614,570	10 / 14
2026-09-10	$-0.04	$1,396,614,570	10 / 14
2026-09-11	$-0.04	$1,396,614,570	10 / 14
2026-09-12	$-0.04	$1,395,975,640	10 / 14
2026-09-13	$-0.04	$1,395,975,640	10 / 14
2026-09-14	$-0.04	$1,395,975,640	10 / 14
2026-09-15	$-0.04	$1,395,975,640	10 / 14
2026-09-16	$-0.04	$1,395,975,640	10 / 14
2026-09-17	$-0.04	$1,395,975,640	10 / 14
2026-09-18	$-0.04	$1,395,975,640	10 / 14
2026-09-19	$-0.04	$1,395,975,640	10 / 14
2026-09-20	$-0.04	$1,395,975,640	10 / 15
2026-09-21	$-0.04	$1,395,975,640	10 / 15
2026-09-22	$-0.04	$1,395,975,640	10 / 15
2026-09-23	$-0.04	$1,395,975,640	10 / 15
2026-09-24	$-0.04	$1,395,975,640	10 / 15
2026-09-25	$-0.04	$1,395,975,640	10 / 15
2026-09-26	$-0.04	$1,395,975,640	10 / 15
2026-09-27	$-0.04	$1,395,975,640	10 / 15
2026-09-28	$-0.04	$1,395,975,640	10 / 15
2026-09-29	$-0.04	$1,395,975,640	10 / 15
2026-09-30	$-0.04	$1,395,975,640	10 / 15
2026-10-01	$-0.04	$1,395,975,640	10 / 15
2026-10-02	$-0.04	$1,395,975,640	10 / 15
2026-10-03	$-0.03	$1,394,534,831	10 / 15
2026-10-04	$-0.03	$1,394,534,831	10 / 15
2026-10-05	$-0.03	$1,394,534,831	10 / 15
2026-10-06	$-0.03	$1,394,534,831	10 / 15
2026-10-07	$-0.03	$1,394,534,831	10 / 15
2026-10-08	$-0.03	$1,394,534,831	10 / 15
2026-10-09	$-0.03	$1,394,534,831	10 / 15
2026-10-10	$-0.03	$1,394,534,831	10 / 15
2026-10-11	$-0.02	$1,394,534,831	10 / 14
2026-10-12	$-0.02	$1,394,736,881	10 / 14
2026-10-13	$-0.02	$1,394,736,881	10 / 14
2026-10-14	$-0.02	$1,394,736,881	10 / 14
2026-10-15	$-0.02	$1,394,736,881	10 / 14
2026-10-16	$-0.03	$1,382,492,267	10 / 15
2026-10-17	$-0.03	$1,382,492,267	10 / 15
2026-10-18	$-0.04	$1,364,282,656	10 / 15
2026-10-19	$-0.04	$1,364,282,656	10 / 15
2026-10-20	$-0.04	$1,364,282,656	10 / 15
2026-10-21	$-0.04	$1,364,282,656	10 / 15
2026-10-22	$-0.04	$1,364,282,656	10 / 15
2026-10-23	$-0.04	$1,364,282,656	10 / 15
2026-10-24	$-0.04	$1,364,282,656	10 / 15

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	14	5
2026-06-01	15	4
2026-07-01	14	4
2026-08-01	14	4
2026-09-01	16	4
2026-10-01	18	4

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 18 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades5 maintains

Recent actions · Sep 25–Oct 24 · 5 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

NeedhamOct 16

$120.00New observation · no comparable prior

KeyBancOct 15 · prior Jun 15

$135.00 → $100.00-25.9%

BarclaysOct 8

$85.00New observation · no comparable prior

$0$74.25$148.50

0 raises · 1 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Adjusted EBITDA loss limited to $20M-$26M in Q2 2026Direct metric needs a verified mapping
Gross margin between 33% and 35% in Q2 2026Gross margin: 36.13%
Revenue between $225M and $240M in Q2 2026Revenue: $234.066M

Next proof point

Nov 9, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.8%Typical daily move · historical

Downside history

-66.2%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Rocket Lab Corp. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a high-risk growth and execution story, not a proven profitable compounder. The long-term thesis is on watch: revenue and backlog have grown, while recent performance is weak and company momentum has dropped sharply.

What's priced into Rocket Lab Corp.

The valuation model shows a premium versus peers, with some support from the potential value of future opportunities, or optionality. The expectations gap is negative, which suggests expectations may be ahead of what current fundamentals support; confidence in that estimate is low, and the evidence does not give a firm valuation conclusion.

What the fundamentals likely do

Near term, the company has reported higher revenue and a larger backlog, while continuing work on Neutron; its first launch timing has shifted to 2027. Momentum has weakened, earnings surprises have been trending down, and management execution is described as volatile, though the stated risk of a near-term miss is low.

What Rocket Lab Corp. hinges on

Over the next few quarters, the thesis depends on avoiding a guidance cut and sustaining revenue and backlog growth. Over the multi-year view, key swing factors are closing the Iridium acquisition as expected, managing its funding, and delivering Neutron after the schedule adjustment. Industrial-sector results could also strengthen or weaken the sector backdrop.

Bottom line

The 1-3 year view combines evidence of growth with substantial execution and sector risks, and the current thesis remains on watch. The key test is whether growth and major projects progress without further weakening in guidance or operating momentum. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$250M–$265M	—
EBITDA	-$23M–-$17Mnon-GAAP	—
Gross margin	29%–31%GAAP 35%–37%non-GAAP	—
Operating expenses	$143M–$149MGAAP $121M–$127Mnon-GAAP	—
FY 2026 · Q4
Revenue	—	264.61M
EPS	—	-0.053
FY 2026 · Annual
Revenue	—	959.07M
EPS	—	-0.286
FY 2027 · Annual
Revenue	—	1.36B
EPS	—	-0.042

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$-0.04

$-0.03 → $-0.04 · observed estimates

FY2027 revenue$1.36B

$1.28B → $1.36B · observed estimates

Exact estimates & source dates

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$-0.03	$1,281,164,390	11 / 17
2026-07-25	$-0.00	$1,278,909,916	9 / 14
2026-07-26	$-0.00	$1,278,909,916	9 / 14
2026-07-27	$-0.03	$1,281,164,390	11 / 17
2026-07-28	$-0.00	$1,278,909,916	9 / 14
2026-07-29	$-0.03	$1,270,674,670	11 / 16
2026-07-30	$-0.00	$1,314,692,699	9 / 14
2026-07-31	$-0.00	$1,314,692,699	9 / 13
2026-08-01	$-0.00	$1,314,692,699	9 / 13
2026-08-02	$-0.03	$1,270,674,670	11 / 16
2026-08-03	$-0.00	$1,314,692,699	9 / 13
2026-08-04	$-0.03	$1,270,674,670	11 / 16
2026-08-05	$-0.04	$1,286,382,040	12 / 17
2026-08-06	$-0.00	$1,314,692,699	9 / 13
2026-08-08	$-0.00	$1,314,692,699	9 / 13
2026-08-09	$-0.04	$1,286,382,040	12 / 17
2026-08-10	$-0.00	$1,314,692,699	9 / 13
2026-08-12	$-0.06	$1,342,130,790	11 / 16
2026-08-13	$-0.06	$1,342,130,790	11 / 16
2026-08-14	$-0.00	$1,314,692,699	9 / 13
2026-08-15	$-0.00	$1,314,692,699	9 / 13
2026-08-16	$-0.00	$1,314,692,699	9 / 13
2026-08-17	$-0.00	$1,314,692,699	9 / 13
2026-08-18	$-0.00	$1,314,692,699	9 / 13
2026-08-19	$-0.00	$1,314,692,699	9 / 13
2026-08-20	$-0.04	$1,394,280,534	9 / 13
2026-08-21	$-0.04	$1,394,280,569	9 / 14
2026-08-22	$-0.04	$1,394,280,569	9 / 14
2026-08-23	$-0.04	$1,394,280,569	9 / 14
2026-08-24	$-0.04	$1,394,280,569	9 / 14
2026-08-25	$-0.04	$1,394,280,569	9 / 14
2026-08-26	$-0.04	$1,394,280,569	9 / 14
2026-08-27	$-0.04	$1,394,280,569	9 / 14
2026-08-28	$-0.04	$1,394,280,569	9 / 14
2026-08-29	$-0.04	$1,394,280,569	9 / 14
2026-08-30	$-0.04	$1,394,280,569	9 / 14
2026-08-31	$-0.04	$1,400,533,075	9 / 14
2026-09-01	$-0.04	$1,400,533,075	9 / 14
2026-09-02	$-0.04	$1,400,533,075	9 / 14
2026-09-03	$-0.04	$1,396,614,570	9 / 14
2026-09-04	$-0.04	$1,396,614,570	9 / 14
2026-09-05	$-0.04	$1,396,614,570	9 / 14
2026-09-06	$-0.04	$1,396,614,570	9 / 14
2026-09-07	$-0.04	$1,396,614,570	9 / 14
2026-09-08	$-0.04	$1,396,614,570	9 / 14
2026-09-09	$-0.04	$1,396,614,570	10 / 14
2026-09-10	$-0.04	$1,396,614,570	10 / 14
2026-09-11	$-0.04	$1,396,614,570	10 / 14
2026-09-12	$-0.04	$1,395,975,640	10 / 14
2026-09-13	$-0.04	$1,395,975,640	10 / 14
2026-09-14	$-0.04	$1,395,975,640	10 / 14
2026-09-15	$-0.04	$1,395,975,640	10 / 14
2026-09-16	$-0.04	$1,395,975,640	10 / 14
2026-09-17	$-0.04	$1,395,975,640	10 / 14
2026-09-18	$-0.04	$1,395,975,640	10 / 14
2026-09-19	$-0.04	$1,395,975,640	10 / 14
2026-09-20	$-0.04	$1,395,975,640	10 / 15
2026-09-21	$-0.04	$1,395,975,640	10 / 15
2026-09-22	$-0.04	$1,395,975,640	10 / 15
2026-09-23	$-0.04	$1,395,975,640	10 / 15
2026-09-24	$-0.04	$1,395,975,640	10 / 15
2026-09-25	$-0.04	$1,395,975,640	10 / 15
2026-09-26	$-0.04	$1,395,975,640	10 / 15
2026-09-27	$-0.04	$1,395,975,640	10 / 15
2026-09-28	$-0.04	$1,395,975,640	10 / 15
2026-09-29	$-0.04	$1,395,975,640	10 / 15
2026-09-30	$-0.04	$1,395,975,640	10 / 15
2026-10-01	$-0.04	$1,395,975,640	10 / 15
2026-10-02	$-0.04	$1,395,975,640	10 / 15
2026-10-03	$-0.03	$1,394,534,831	10 / 15
2026-10-04	$-0.03	$1,394,534,831	10 / 15
2026-10-05	$-0.03	$1,394,534,831	10 / 15
2026-10-06	$-0.03	$1,394,534,831	10 / 15
2026-10-07	$-0.03	$1,394,534,831	10 / 15
2026-10-08	$-0.03	$1,394,534,831	10 / 15
2026-10-09	$-0.03	$1,394,534,831	10 / 15
2026-10-10	$-0.03	$1,394,534,831	10 / 15
2026-10-11	$-0.02	$1,394,534,831	10 / 14
2026-10-12	$-0.02	$1,394,736,881	10 / 14
2026-10-13	$-0.02	$1,394,736,881	10 / 14
2026-10-14	$-0.02	$1,394,736,881	10 / 14
2026-10-15	$-0.02	$1,394,736,881	10 / 14
2026-10-16	$-0.03	$1,382,492,267	10 / 15
2026-10-17	$-0.03	$1,382,492,267	10 / 15
2026-10-18	$-0.04	$1,364,282,656	10 / 15
2026-10-19	$-0.04	$1,364,282,656	10 / 15
2026-10-20	$-0.04	$1,364,282,656	10 / 15
2026-10-21	$-0.04	$1,364,282,656	10 / 15
2026-10-22	$-0.04	$1,364,282,656	10 / 15
2026-10-23	$-0.04	$1,364,282,656	10 / 15
2026-10-24	$-0.04	$1,364,282,656	10 / 15

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings